Filter & sort
The latest funding rounds from the UK tech ecosystem. Updated 16 October 2026.
Announcements
238
Total raised
£3.1B
disclosed amounts
This month
£7.8M
raised so far
The funding round was led by Technology Venture Partners alongside government backing to support the commercialisation of a new breast scanning system.
"this investment will allow us to move the company into the next phase with a system that has a place in a clinical workflow and more exciting functionality to come as soon as clinical data collection can re commence"
Origin Capital co-led the £2.1m funding round for the nanoparticle technology developer.
The University of Edinburgh spin-out has secured backing to fund its first human trials.
"The BioCollector is a disruptive technology which will be transformational for liquid biopsy testing. We are confident that this platform technology can make a significant impact in this important area and, ultimately, enable cancers to be detected more quickly and accurately, enabling patients to receive precision cancer treatment as early as possible."
The financing round was led by Vulpes Investment Management with backing from existing investors to fund first in-human data acquisition.
"The current device market for brain aneurysms is valued at well over $1bn and is growing rapidly year-on-year. One of the biggest challenges when it comes to treating neurovascular disease is having devices with high efficacy whilst minimising adverse events. Studies show that often multiple attempts are made to place treatment devices, as they often have challenges of landing accurately, opening and maintaining position. This can lead to adverse events and multiple devices being used. Procedures typically cost over $50,000 to treat a brain aneurysm and a next generation flow diverter overcoming unmet needs, offers the chance for more effective, safer and cost effective treatments as well as allowing many more patients to benefit. We plan to use this funding to bring Oxford Endovascular’s ground-breaking technology to the next stage and gain clinical data from human studies."
The Milton Keynes based dental technology firm has secured debt backing from Maven Capital Partners to launch a new browser based management system.
"The MEIF was designed to fill gaps in access to finance and provide greater options for Midlands’ businesses. Wysdom Dental is the latest investment to be made by the Fund in a technology business, enabling more new, innovative products to be developed and taken to market and supporting economic recovery following the disruption caused by the Covid-19 pandemic."
